Cure My Disease

Don't miss your cure!

 Log in / Sign up

Extended trial tests new sleep disorder medication

NCT ID NCT06767683

Recruiting now Disease control Sponsor: Alkermes, Inc. Source: ClinicalTrials.gov ↗

Summary

This study continues testing ALKS 2680 tablets for people with narcolepsy or idiopathic hypersomnia who completed earlier trials. Researchers want to see how safe the medication is over a longer period and whether its benefits last. Participants will take the tablets regularly to help control their excessive daytime sleepiness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alkermes Investigational Site

    RECRUITING

    Little Rock, Arkansas, 72211, United States

  • Alkermes Investigational Site

    RECRUITING

    Los Angeles, California, 90025, United States

  • Alkermes Investigational Site

    RECRUITING

    Stanford, California, 94305, United States

  • Alkermes Investigational Site

    RECRUITING

    Colorado Springs, Colorado, 80918, United States

  • Alkermes Investigational Site

    RECRUITING

    Brandon, Florida, 33511, United States

  • Alkermes Investigational Site

    RECRUITING

    Miami, Florida, 33176, United States

  • Alkermes Investigational Site

    RECRUITING

    Winter Park, Florida, 32789, United States

  • Alkermes Investigational Site

    RECRUITING

    Atlanta, Georgia, 30328, United States

  • Alkermes Investigational Site

    RECRUITING

    Macon, Georgia, 31210, United States

  • Alkermes Investigational Site

    RECRUITING

    Stockbridge, Georgia, 30281, United States

  • Alkermes Investigational Site

    RECRUITING

    Peoria, Illinois, 61637, United States

  • Alkermes Investigational Site

    RECRUITING

    Lansing, Michigan, 48911, United States

  • Alkermes Investigational Site

    RECRUITING

    Sterling Heights, Michigan, 48314, United States

  • Alkermes Investigational Site

    RECRUITING

    Lincoln, Nebraska, 68506, United States

  • Alkermes Investigational Site

    RECRUITING

    Middletown, New Jersey, 07748, United States

  • Alkermes Investigational Site

    RECRUITING

    Denver, North Carolina, 28037, United States

  • Alkermes Investigational Site

    RECRUITING

    Huntersville, North Carolina, 28708, United States

  • Alkermes Investigational Site

    RECRUITING

    Canton, Ohio, 44718, United States

  • Alkermes Investigational Site

    RECRUITING

    Cincinnati, Ohio, 45212, United States

  • Alkermes Investigational Site

    RECRUITING

    Cincinnati, Ohio, 45245, United States

  • Alkermes Investigational Site

    RECRUITING

    Dublin, Ohio, 43017, United States

  • Alkermes Investigational Site

    RECRUITING

    Abington, Pennsylvania, 19001, United States

  • Alkermes Investigational Site

    RECRUITING

    Wyomissing, Pennsylvania, 19610, United States

  • Alkermes Investigational Site

    RECRUITING

    Columbia, South Carolina, 29201, United States

  • Alkermes Investigational Site

    RECRUITING

    Austin, Texas, 78731, United States

  • Alkermes Investigational Site

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Alkermes Investigational Site

    RECRUITING

    Sugar Land, Texas, 77478, United States

  • Alkermes Investigational Site

    RECRUITING

    Madison, Wisconsin, 53706, United States

  • Alkermes Investigational Site

    RECRUITING

    Sydney, New South Wales, 2113, Australia

  • Alkermes Investigational Site

    RECRUITING

    Bedford Park, South Australia, 5042, Australia

  • Alkermes Investigational Site

    RECRUITING

    Clayton, Victoria, 3168, Australia

  • Alkermes Investigational Site

    RECRUITING

    Bruges, Brugge, 8000, Belgium

  • Alkermes Investigational Site

    RECRUITING

    Alken, 3570, Belgium

  • Alkermes Investigational Site

    RECRUITING

    Namur, 5101, Belgium

  • Alkermes Investigational Site

    RECRUITING

    Prague, 128 21, Czechia

  • Alkermes Investigational Site

    RECRUITING

    Montpellier, Herault, 34295, France

  • Alkermes Investigational Site

    RECRUITING

    Bordeaux, 33000, France

  • Alkermes Investigational Site

    RECRUITING

    Bologna, 40139, Italy

  • Alkermes Investigational Site

    RECRUITING

    Milan, 20127, Italy

  • Alkermes Investigational Site

    RECRUITING

    Verona, 37134, Italy

  • Alkermes Investigational Site

    RECRUITING

    Zwolle, 8025, Netherlands

  • Alkermes Investigational Site

    RECRUITING

    Madrid, Madrid, 28036, Spain

  • Alkermes Investigational Site

    RECRUITING

    Barcelona, 08036, Spain

  • Alkermes Investigational Site

    RECRUITING

    Madrid, 28043, Spain

  • Alkermes Investigator Site

    RECRUITING

    Phoenix, Arizona, 85054, United States

  • Alkermes Investigator Site

    RECRUITING

    San Francisco, California, 94158, United States

Conditions

Explore the condition pages connected to this study.

IDIOPATHIC HYPERSOMNIA NARCOLEPSY TYPE 1 NARCOLEPSY TYPE 2